Q32 BIO INC

Q32 BIO’s zero‑priced insider option grants signal strong board confidence in the company’s biotech pipeline and future upside—why investors are watching closely.

Insider buying frenzy at Q32 BIO: Xu Diyong and OrbiMed buy millions of shares at $8.00, signaling confidence in the company’s growth and a potential upside.

Kalowski Lee’s recent $355k buy of Q32 Bio shares signals renewed insider confidence amid a strong rally and potential partnership news.

Q32 Bio insiders sell RSU‑triggered shares at $4.51; routine tax‑related sales keep the CEO, CFO and CSO’s long‑term stake strong amid a 13% monthly price climb.

Grayzel David S. exercises Q32 Bio’s newly granted stock option, adding 16,363 shares and signalling cautious long‑term confidence in the biotech’s gene‑correction platform.